ENQ.L

EnQuest Plc
EnQuest PLC - Transaction in Own Shares
29th November 2024, 07:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 0943O
EnQuest PLC
29 November 2024
 

FOR IMMEDIATE RELEASE                                                                              29 November 2024

 

ENQUEST PLC ("EnQuest" or "the Company")

TRANSACTIONS IN OWN SHARES

EnQuest PLC (the "Company") announces that, on 28 November 2024, it purchased the following number of its ordinary shares of 5 pence each (the "Ordinary Shares") through Merrill Lynch International ("Merrill Lynch"). Such purchase was effected pursuant to the instructions issued by the Company in accordance with the share repurchase arrangements entered into with Merrill Lynch, as announced on 29 April 2024.

Aggregated information of Ordinary Shares purchased on 28 November 2024 according to each trading venue:

Venue

Weighted average price paid per share (GBp)

Aggregate number of shares purchased

Lowest price paid per share (GBp)

Highest price paid per share (GBp)

London Stock Exchange

11.00

89,453

10.98

11.14

Chi-X

10.97

7,488

10.92

11.02

BATS

11.07

42,887

10.98

11.12

Turquoise

11.00

1,686

11.00

11.00

Total (all venues)

11.02

141,514

10.92

11.14

 

Since 29 April 2024, the Company has purchased 49,992,206 Ordinary Shares at a cost (including dealing and associated costs) of £6,372,974.93. Of those shares, 25,000,000 Ordinary Shares have been retained in Treasury and will be issued in due course to the Company's Employee Benefit Trust and 24,992,206 Ordinary Shares have been purchased for cancellation.

Following the cancellation of the purchased shares, there will be 1,890,932,133 Ordinary Shares in issue and 25,000,000 Shares in Treasury. The total voting rights in the Company will accordingly be 1,865,932,133.

This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

A full breakdown of the individual trades made by Merrill Lynch on behalf of the Company as part of the share repurchase programme is attached to this document.

Attachment: http://www.rns-pdf.londonstockexchange.com/rns/0943O_1-2024-11-28.pdf

 

LEI: 2138008LJU6WFQWOXJ73

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

Enquiries:

 

EnQuest plc                                                                 +44 (0)20 7925 4900

Kate Christ, Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBRBDBCXDDGSI]]>
TwitterFacebookLinkedIn